OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 113 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $98,850,362 | -4.4% | 9,135,893 | 0.0% | 2.77% | -2.6% |
Q1 2024 | $103,418,309 | -19.3% | 9,135,893 | 0.0% | 2.84% | -11.4% |
Q4 2023 | $128,176,579 | +13.6% | 9,135,893 | 0.0% | 3.21% | +5.5% |
Q3 2023 | $112,828,279 | +64.2% | 9,135,893 | +20.0% | 3.04% | +58.8% |
Q2 2023 | $68,731,872 | +160.2% | 7,611,503 | 0.0% | 1.92% | +98.5% |
Q1 2023 | $26,411,915 | +41.6% | 7,611,503 | 0.0% | 0.96% | +22.6% |
Q4 2022 | $18,648,182 | -11.2% | 7,611,503 | 0.0% | 0.79% | -9.3% |
Q3 2022 | $21,008,000 | -32.2% | 7,611,503 | 0.0% | 0.87% | -42.0% |
Q2 2022 | $30,979,000 | -1.9% | 7,611,503 | +2.7% | 1.50% | +18.4% |
Q1 2022 | $31,573,000 | -54.5% | 7,411,503 | 0.0% | 1.26% | -49.8% |
Q4 2021 | $69,372,000 | -62.2% | 7,411,503 | +11.3% | 2.52% | -64.8% |
Q3 2021 | $183,591,000 | -1.5% | 6,661,503 | 0.0% | 7.16% | +2.5% |
Q2 2021 | $186,389,000 | -15.7% | 6,661,503 | 0.0% | 6.99% | -15.7% |
Q1 2021 | $221,029,000 | -31.0% | 6,661,503 | 0.0% | 8.29% | -34.2% |
Q4 2020 | $320,285,000 | – | 6,661,503 | – | 12.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 2,654,867 | $28,725,661 | 4.46% |
Paradigm Biocapital Advisors LP | 7,903,600 | $85,516,952 | 3.27% |
Logos Global Management LP | 3,208,875 | $34,720,028 | 2.82% |
BVF INC/IL | 9,135,893 | $98,850,362 | 2.77% |
Vivo Capital, LLC | 1,873,704 | $20,273,477 | 1.87% |
Ghost Tree Capital, LLC | 550,000 | $5,951,000 | 1.86% |
GREAT POINT PARTNERS LLC | 796,880 | $8,622,242 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 546,863 | $5,917,058 | 1.40% |
Deep Track Capital, LP | 4,000,000 | $43,280,000 | 1.29% |
HighVista Strategies LLC | 247,880 | $2,682,062 | 0.98% |